Global Leadership Antibiotice is the world's leading producer of Nystatin, recognized by the United States Pharmacopeia as the international standard since 2017, offering a strong foundation for expanding pharmaceutical ingredient sales and collaborations internationally.

Expanding R&D Capacity The company's recent $81.9 million investment in a new research and development center focused on critical medicines presents opportunities to market specialized pharmaceutical solutions and innovative drug development collaborations.

Funding & Growth With recent financing of over $77 million from Banca Transilvania to support strategic projects, there is potential to explore co-investment opportunities, joint ventures, and new product launches that align with their growth objectives.

Market Penetration Antibiotice’s significant presence in over 70 countries and its role as Romania's main provider of anti-infectives positions it well for expansion into new markets with high demand for affordable, high-quality generic and active pharmaceutical ingredients.

Quality & Compliance Maintaining certifications such as EU-GMP, FDA, and European Pharmacopoeia compliance highlights their focus on quality, opening doors for partnerships that require strict regulatory adherence and high standards in pharmaceutical manufacturing.